FDA Inspection 1247099 — Ahmadshah S. Mirkhel, M.D.

Ahmadshah S. Mirkhel, M.D. — FEI 3031305260

The FDA completed an inspection of Ahmadshah S. Mirkhel, M.D. on August 9, 2024 in Fairfax, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 9, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Fairfax, VA (United States)

Additional Details

Clinical Investigator (CI)